Bước đột phá trong điều trị tăng huyết áp 2018 - PGS.TS Trương Quang Bình

BƯỚC ĐỘT PHÁ TRONG<br /> ĐIỀU TRỊ TĂNG HUYẾT ÁP<br /> 2018<br /> PGS TS Trương Quang Bình<br /> ĐHYD TP HCM<br /> <br /> Hypertension: the facts<br /> <br /> 2<br /> <br /> World Health Organization: World<br /> <br /> http://www.paho.org/hipertension<br /> <br /> Prevalence, awareness, treatment and control<br /> rates of hypertension in Asia (1)<br /> Number of<br /> subjects<br /> <br /> Prevalence<br /> <br /> Awareness<br /> <br /> Treated<br /> <br /> Controlled<br /> <br /> Bangladesh 2011<br /> <br /> 7876<br /> <br /> 24.4％<br /> <br /> 50.1％<br /> <br /> 41.2%<br /> <br /> 31.4%<br /> <br /> Cambodia 2010<br /> (25-64 y)2<br /> <br /> 5433<br /> <br /> 12.3％<br /> <br /> 45.4％<br /> <br /> 19.2%<br /> <br /> 13.0%<br /> <br /> China 2002<br /> <br /> 141,892<br /> <br /> 18.8％<br /> <br /> 30.2％<br /> <br /> 24.7％<br /> <br /> 6.1％<br /> <br /> India 19502013 (>18 y)4<br /> <br /> 326,644<br /> <br /> 29.9％<br /> <br /> Indonesia 2002<br /> <br /> 3080<br /> <br /> 58.9％<br /> <br /> -％<br /> <br /> 62.7%<br /> <br /> 25.0%<br /> <br /> Iran 2012<br /> (18-65 y)6<br /> <br /> 3497<br /> <br /> 21.2％<br /> <br /> 58.7％<br /> <br /> 51.0%<br /> <br /> 21.9%<br /> <br /> 25.3％<br /> 42.0%<br /> <br /> 25.1%<br /> 37.6%<br /> <br /> 10.7%<br /> 20.2%<br /> <br /> 1. J Hypertens 2015, 33:465. 2. Otgontuya et al. BMC Public Health 2012;12:254. 3. Li L, et al. ChinJ E pidemiol 2005; 26:<br /> 478. 4. J Hypertens 2014, 32:1170. 5. Setiati S et al. Indones J Intern Med 2005;37:20-25. 6. J CV Thorac Res 2012; 4, 37.<br /> <br /> Prevalence, awareness, treatment and<br /> control rates of hypertension in Asia (2)<br /> Number of<br /> patients<br /> <br /> Prevalence<br /> <br /> Awareness<br /> <br /> Treated<br /> <br /> Controlled<br /> <br /> -<br /> <br /> 43 million<br /> <br /> -％<br /> <br /> -50%<br /> <br /> -35%<br /> <br /> 9146<br /> <br /> 24.9％<br /> <br /> 60.6％<br /> <br /> 52.2％<br /> <br /> 36.7％<br /> <br /> Malaysia 2006<br /> <br /> 16,440<br /> <br /> 27.8％<br /> <br /> 34.6％<br /> <br /> 32.4%<br /> <br /> 26.8％<br /> <br /> Mongolia 2009<br /> (25-64 y)10<br /> <br /> 4539<br /> <br /> 36.5％<br /> <br /> 65.8％<br /> <br /> 34.8%<br /> <br /> 15.9%<br /> <br /> Nepal<br /> 2010 (>20 y)11<br /> <br /> 14,009<br /> <br /> 33.9％<br /> <br /> 37.0％<br /> <br /> 25.1%<br /> <br /> -％<br /> <br /> 8972<br /> <br /> 19.6％<br /> <br /> -％<br /> <br /> -％<br /> <br /> -％<br /> <br /> Japan NIPPON data<br /> 20107<br /> Korea 20072008 (>30 y)8<br /> <br /> Pakistan 19901994<br /> <br /> 7. NIPPON data 2010. 8. Lee HS, et al. J Hum Hypertens. 2013 Jun;27(6):381. 9. Public Health 2008;122:11. 10.<br /> Otgontuya et al. BMC Public Health 2012;12:254. 11. Int J Hypertens 2011;82197112. 12. CMAJ 2006 ;175:1071.<br /> <br /> Prevalence, awareness, treatment and<br /> control rates of hypertension in Asia (3)<br /> Number of<br /> patients<br /> <br /> Prevalence<br /> <br /> Awareness<br /> <br /> Treated<br /> <br /> Controlled<br /> <br /> Saudi 2005<br /> (15-64 y)13<br /> <br /> 4,758<br /> <br /> 25.5％<br /> <br /> 44.7％<br /> <br /> 32.1％<br /> <br /> 16.5％<br /> <br /> Singapore<br /> 200414<br /> 2007 (24 y)<br /> <br /> 5,022<br /> <br /> 41.5％<br /> <br /> 51.8％<br /> <br /> 43.7％<br /> <br /> 11.8％<br /> <br /> Thailand 2004<br /> <br /> 39,290<br /> <br /> 22.0％<br /> <br /> 69.8％<br /> <br /> 54.6％<br /> <br /> 20.0%<br /> <br /> Viet Nam 2012<br /> <br /> 9,832<br /> <br /> 25.1％<br /> <br /> 48.4％<br /> <br /> 29.6％<br /> <br /> 10.7％<br /> <br /> 220,539<br /> <br /> 27.1％<br /> <br /> -％<br /> <br /> -％<br /> <br /> -％<br /> <br /> SAARC 20002013 (meta)17<br /> <br /> 13. Int J Hypertens 2011;174135. 14. J Hypertens 2009;27:190. 15. J Hypertens 2008;26:191. 16. Son PT, et al. J Hum<br /> Hypertens. 2012;26:268. 17. Neupane D, et al. Medicine 2014;93:e74.<br /> <br />